Winning Health Technology Group Co

Winning Health Technology Group Co ROE

The Return on Equity (ROE) of Winning Health Technology Group Co (300253.SZ) as of Oct 20, 2026 is -6.69 %. In the previous year, Return on Equity (ROE) was 1.47 % — a change of -553.96% (lower).

ROE

-6.69 %

YoY

-553.96%

Last updated:

In 2025, Winning Health Technology Group Co's return on equity (ROE) was -6.69 %, a -553.96% increase from the 1.47 % ROE in the previous year.

The Winning Health Technology Group Co ROE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROE
Date
ROE
Jan 1, 2018
9.50 CNY
Jan 1, 2019
10.65 CNY
Jan 1, 2020
10.86 CNY
Jan 1, 2021
7.42 CNY
Jan 1, 2022
2.13 CNY
Jan 1, 2023
6.29 CNY
Jan 1, 2024
1.47 CNY
Jan 1, 2025
-6.69 CNY
The Winning Health Technology Group Co ROE history
YEARROEYoY
-6.69 %-553.96%
1.47 %-76.58%
6.29 %+196.05%
2.13 %-71.33%
7.42 %-31.72%
10.86 %+1.98%
10.65 %+12.11%
9.50 %+7.68%
8.82 %-60.21%
22.17 %+47.30%
15.05 %-4.42%
15.75 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Winning Health Technology Group Co Stock analysis

What does Winning Health Technology Group Co do? Winning Health Technology Group Co Ltd generates revenue through the development, sales, and technical services of medical software products. The company offers hospital information systems, public health information management systems, and regional data exchange platforms, including hospital information management systems, medical information management systems, community health information systems, and rural health integrated solutions. Its primary customers are hospitals, public health institutions, and government agencies responsible for healthcare management and disease prevention. The firm targets medium- and small-scale hospitals, as well as regional health authorities seeking comprehensive digital solutions for healthcare informatization. The company's product portfolio includes disease prevention and control systems, pharmaceutical centralized bidding systems, and pharmaceutical trade monitoring systems, which are sold to healthcare providers and government bodies managing pharmaceutical distribution. Regional health statistics analysis systems are also part of its offerings, catering to public health departments requiring data-driven insights. Winning Health Technology Group Co Ltd focuses on delivering end-to-end software solutions tailored to the needs of the medical and health industry, emphasizing technical support and system integration for its clients. Revenue streams are derived from the licensing of its software products and the provision of technical services for system implementation and maintenance. The firm serves a diverse client base within the healthcare sector, including hospitals, community health centers, and government health departments. Its solutions address key areas such as patient management, public health monitoring, and pharmaceutical logistics, ensuring compliance with regional healthcare standards and regulations. Winning Health Technology Group Co is one of the most popular companies on Eulerpool.

ROE Details

Decoding Winning Health Technology Group Co's Return on Equity (ROE)

Winning Health Technology Group Co's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Winning Health Technology Group Co's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Winning Health Technology Group Co's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Winning Health Technology Group Co’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Winning Health Technology Group Co stock

Return on Equity (ROE) of Winning Health Technology Group Co is -6.69 % in 2025.

Return on Equity (ROE) of Winning Health Technology Group Co changed from 1.47 % to -6.69 %, representing a -553.96% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Winning Health Technology Group Co since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Winning Health Technology Group Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Profitability — Winning Health Technology Group Co

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — Winning Health Technology Group Co